Integer Holdings Co. (NYSE:ITGR) Shares Acquired by Xponance Inc.

Xponance Inc. boosted its position in Integer Holdings Co. (NYSE:ITGR) by 9.5% in the 4th quarter, HoldingsChannel reports. The firm owned 2,396 shares of the medical equipment provider’s stock after purchasing an additional 207 shares during the period. Xponance Inc.’s holdings in Integer were worth $318,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ITGR. Raymond James Financial Inc. purchased a new stake in shares of Integer in the fourth quarter valued at $38,073,000. Laurus Investment Counsel Inc. purchased a new stake in Integer in the 4th quarter valued at about $5,422,000. New York State Common Retirement Fund increased its stake in shares of Integer by 20.9% during the 4th quarter. New York State Common Retirement Fund now owns 232,569 shares of the medical equipment provider’s stock valued at $30,820,000 after acquiring an additional 40,158 shares during the last quarter. Bamco Inc. NY lifted its holdings in shares of Integer by 17.4% during the 3rd quarter. Bamco Inc. NY now owns 254,377 shares of the medical equipment provider’s stock worth $33,069,000 after acquiring an additional 37,700 shares during the period. Finally, Wealthfront Advisers LLC acquired a new stake in shares of Integer in the fourth quarter worth approximately $4,754,000. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Integer Price Performance

ITGR stock opened at $117.74 on Friday. The stock has a 50-day simple moving average of $130.95 and a 200-day simple moving average of $132.02. The firm has a market cap of $3.96 billion, a P/E ratio of 35.04, a price-to-earnings-growth ratio of 1.72 and a beta of 1.24. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. Integer Holdings Co. has a 1 year low of $107.11 and a 1 year high of $146.36.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). The firm had revenue of $449.50 million for the quarter, compared to analysts’ expectations of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. On average, equities analysts predict that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts recently commented on ITGR shares. KeyCorp upped their price target on shares of Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Truist Financial upped their price objective on Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Oppenheimer cut Integer from an “outperform” rating to a “market perform” rating in a report on Friday, February 21st. Wells Fargo & Company restated an “overweight” rating and set a $160.00 price target on shares of Integer in a research note on Tuesday, December 3rd. Finally, Citigroup lifted their price objective on Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research note on Wednesday, December 11th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $149.00.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.